Authors
Latest:
How Can AI Improve Patient Care?AI’s ability to quickly process and interpret large quantities of health data is a valuable tool for physicians.
Latest:
Drug Combination May Benefit Patients with Transplanted Kidneys, Advanced Skin CancersIn most kidney transplant recipients with advanced skin cancer, 2 checkpoint inhibitors are needed to boost the immune system, according to a new study.
Latest:
Dermatology Times in France: What La Roche-Posay Products Dermatologists Recommend for Eczema, AcneDermatologists Jeanine Downie, DiAnne Davis, and Hope Mitchell reveal the La Roche-Posay products they recommend to patients with dry skin, eczema, and more, at the flagship store in France.
Latest:
Managing Dermatologic Surgery ChallengesDaniel Siegel, MD, shared strategies to manage surgery challenges, especially bleeding, to ensure a smooth experience for patients.
Latest:
Study Underscores Need for More Effective Psoriasis Oral TherapiesSurvey responses revealed the rates and times at which patients switched from oral to biologic therapies.
Latest:
Data Support the Use of First-/Second-Line Immune Checkpoint Inhibitors in HNSCCFindings from a retrospective cohort study found that immune checkpoint inhibitors induced promising responses in the first- and second-line treatment of head and neck squamous cell carcinoma.
Latest:
Dermatologist Talks About the ABCs of Wounds and HS Support at Annual MeetingExpert insights on the latest issues in wounds as well as HS resources are shared at the annual meeting.
Latest:
Holistic Aesthetics Center to Host First Annual Symposium in Middletown, New YorkJeffrey Yager, MD, discusses the new SY Aesthetics campus that will integrate traditional and Chinese healing.
Latest:
Frontline Forum Part 4: Solutions in the Management and Treatment of Basal Cell CarcinomaIn part 4 of this Frontline Forum series, John M. Strasswimmer, MD, PhD; Andrew H. Weinstein, MD; Neal Bhatia, MD; Laura Ferris, MD; and Aaron S. Farberg, MD, discuss solutions for managing and treating patients with basal cell carcinoma.
Latest:
Novel, Nonsurgical BCC Treatment Shown Safe and EffectiveIn this study, researchers treated 37 basal cell carcinoma (BCC) lesions from 30 patients, with follow-ups at 5 time points after baseline examination.
Latest:
How Managing Comorbidities Can Transform Alopecia Areata Treatment OutcomesUnderstanding comorbidities such as thyroid dysfunction and vitiligo helps to navigate comprehensive care to achieve long-lasting results in alopecia areata treatment.
Latest:
The Crystal Ball: What This Means for the Future of Atopic Dermatitis TreatmentsPeter Lio, MD, reflects on current unmet needs in atopic dermatitis and suggests directions for future research and development.
Latest:
Anna López-Ferrer, MD, PhD, and Volker Koscielny, MD, MBA, Share Highlights From Almirall’s 15th Skin AcademyLópez-Ferrer discussed how to achieve well-being for patients with psoriasis and Koscielny discussed the unique topics of the Skin Academy.
Latest:
The Many Considerations of Managing Generalized Pustular PsoriasisExperts discuss the treatment landscape of generalized pustular psoriasis as well as review difficult cases of GPP.
Latest:
When to Call a Time Out on Mohs SurgeryJerry Brewer, MD, MS, shared pearls on reasons to avoid or discontinue Mohs surgery and keeping calm with stressed, vulnerable patients.
Latest:
Deuruxolitinib Shows Efficacy in Hair Regrowth, Patient Satisfaction, and Psychosocial Wellbeing in Severe Alopecia AreataArash Mostaghimi, MD, MPH, MPA, provides insights into what clinicians need to know about deuruxolitinib for severe AA.
Latest:
Award-Winning Research on Hair Loss Consensus Highlighted at Annual MeetingThe poster, which shares results form consensus research on using LODM for hair loss, was awarded 4th place at the 2024 AAD Annual Meeting.
Latest:
3 Approaches to Creating a Connected Care FutureBy integrating capabilities and services, we can create health experiences that are much more than the sum of their parts.
Latest:
Diving Into Deuruxolitinib Data With Natasha Mesinkovska, MD, PhDThe investigator in the clinical development program for deuruxolitinib shared data, patient populations to consider, and more in a recent interview.
Latest:
Severe Hemorrhage from Infantile HemangiomaA 5-month-old girl with a large scalp infantile hemangioma (IH), present since 6 weeks of age, is evaluated in the emergency department for lethargy and pallor.
Latest:
Understanding Clascoterone Cream: MOA, Patient Selection Criteria, and Gender-Inclusive AdvantagesContinuing the discussion on the case of a 17-year-old patient with moderate acne, Heather Woolery-Lloyd, MD, FAAD, provides an overview of the utilization of clascoterone cream, highlighting the application process and its unique mechanism of action.
Latest:
The Adalimumab Biosimiliar Pipeline: What's AheadFDA approvals of these biosimilars started in 2016, but only 1 such product has successfully launched.
Latest:
Take-home Points to Manage AcneDrs Joshua Zeichner, MD, and Mona Gohara, MD, provide take-home messages to providers treating patients with acne.
Latest:
Shingles Vaccination Counseling During the COVID-19 PandemicCDC advises not to delay shingles vaccination.
Latest:
Katie Martin, PA-C, Share Insights Into Aesthetic Innovations in 2023 and What’s to Come in 2024The approval of Galderma’s Restylane Eyelight was one of Martin’s top highlights of 2023.
Latest:
Parents Worries About Severe Acne’s Impact on TeensMore than 90% of respondents to a recent survey expressed concern about acne’s effect on their adolescent’s mental health and social life.
